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Background
Late gadolinium enhancement (LGE) is associated with
adverse events in adults with hypertrophic cardiomyopa-
thy (HCM). However, the extent and clinical significance
of LGE in the pediatric population has not been well
described. This study sought to characterize the pattern
of LGE and its relation to hypertrophy, strain, and clini-
cal outcomes in pediatric patients with HCM.
Methods
This single center, retrospective study included all
patients 21 years or less with a clinical diagnosis of
HCM who underwent cardiac magnetic resonance
(CMR) from 2007-2012. Using a 16-segment model, seg-
ments with hypertrophy or LGE were identified by
agreement of two experienced readers blinded to out-
come. Circumferential and radial strain were evaluated
by segment, using feature tracking software (TomTec,
Unterschleissheim, Germany). The composite outcome
was defined as death, non-sustained ventricular tachy-
cardia (VT), or ventricular fibrillation (VF).
Results
Thirty patients (mean age 14.1±3.2 years) were included,
with 11 patients (37%) confirmed by genotype. LGE was
present in 17 patients (57%), predominantly in the basal
and mid-ventricular septum and anterior wall, all in a
mid-myocardial pattern, with a median of 3 segments per
patient (interquartile range 2-5). LGE was closely related
to hypertrophy. Patients with LGE had an odds ratio
(OR) of 38.6 for hypertrophy (p<0.001); no LGE was
detected in patients without hypertrophy. Segments with
LGE had decreased radial strain (basal segments 20.7 vs.
70.9%, p=0.01; mid segments 32.1 vs. 62.9%, p=0.0003)
and circumferential strain (basal segments -23.2 vs.
-29.3%, p=0.04; mid segments -26.1 vs. -29.4%, p=0.09).
Decreased strain may be independent of hypertrophy
(radial strain 29.0 vs. 44.7% in segments with hypertrophy
but no LGE, p=0.07). After median follow-up of 12.5
months (interquartile range 4-36), 7 patients had a nega-
tive outcome, with a strong trend toward increased odds
of death, VT, or VF in patients with LGE (OR 6.2, p=0.1).
Patients with an event had more segments of LGE than
patients without an event (median 4 (interquartile range
2-7) vs. 0 (interquartile range 0-2), p=0.01). One episode
of VT occurred in a patient without LGE.
Conclusions
In pediatric patients with HCM, LGE is unlikely to
occur in the absence of hypertrophy. Similar to the
adult HCM population, myocardial deformation is
reduced in areas with LGE. LGE may relate to negative
outcomes in a pediatric population, although further
study is necessary to confirm this relationship in a larger
population, not pre-selected for clinical need of CMR.
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